HKD 9.17
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 5.01 Billion CNY | -18.55% |
2022 | 6.15 Billion CNY | 3.17% |
2021 | 5.96 Billion CNY | -9.54% |
2020 | 6.59 Billion CNY | 10.3% |
2019 | 5.97 Billion CNY | -16.21% |
2018 | 7.13 Billion CNY | 43.62% |
2017 | 4.96 Billion CNY | -4.12% |
2016 | 5.17 Billion CNY | -19.44% |
2015 | 6.42 Billion CNY | 5.28% |
2014 | 6.1 Billion CNY | 35.03% |
2013 | 4.52 Billion CNY | 27.33% |
2012 | 3.55 Billion CNY | -12.4% |
2011 | 4.05 Billion CNY | 0.55% |
2010 | 4.03 Billion CNY | 10.79% |
2009 | 3.63 Billion CNY | 6.06% |
2008 | 3.43 Billion CNY | 30379.52% |
2007 | 11.25 Million CNY | -88.57% |
2006 | 98.44 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 4.09 Billion CNY | 0.0% |
2023 FY | 5.01 Billion CNY | -18.55% |
2023 Q2 | 6.55 Billion CNY | 0.0% |
2023 Q4 | 5.01 Billion CNY | 0.0% |
2022 Q2 | 7.12 Billion CNY | 0.0% |
2022 FY | 6.15 Billion CNY | 3.17% |
2022 Q4 | 6.15 Billion CNY | 0.0% |
2021 Q2 | 6.97 Billion CNY | 0.0% |
2021 FY | 5.96 Billion CNY | -9.54% |
2021 Q4 | 5.96 Billion CNY | 0.0% |
2020 FY | 6.59 Billion CNY | 10.3% |
2020 Q4 | 6.59 Billion CNY | 0.0% |
2020 Q2 | 6.82 Billion CNY | 0.0% |
2019 Q2 | 7.4 Billion CNY | 0.0% |
2019 Q4 | 5.97 Billion CNY | 0.0% |
2019 FY | 5.97 Billion CNY | -16.21% |
2018 Q4 | 7.13 Billion CNY | 0.0% |
2018 FY | 7.13 Billion CNY | 43.62% |
2018 Q2 | 6.21 Billion CNY | 0.0% |
2017 Q2 | 5.28 Billion CNY | 0.0% |
2017 FY | 4.96 Billion CNY | -4.12% |
2017 Q4 | 4.96 Billion CNY | 0.0% |
2016 FY | 5.17 Billion CNY | -19.44% |
2016 Q2 | 5.93 Billion CNY | 0.0% |
2016 Q4 | 5.17 Billion CNY | 0.0% |
2015 Q2 | 6.1 Billion CNY | 0.0% |
2015 FY | 6.42 Billion CNY | 5.28% |
2015 Q4 | 6.42 Billion CNY | 0.0% |
2014 FY | 6.1 Billion CNY | 35.03% |
2014 Q4 | 6.1 Billion CNY | 0.0% |
2014 Q2 | 6.27 Billion CNY | 0.0% |
2013 Q4 | 4.52 Billion CNY | 0.0% |
2013 Q2 | 4.19 Billion CNY | 0.0% |
2013 FY | 4.52 Billion CNY | 27.33% |
2012 Q2 | 3.85 Billion CNY | 0.0% |
2012 Q4 | 3.55 Billion CNY | 0.0% |
2012 FY | 3.55 Billion CNY | -12.4% |
2011 FY | 4.05 Billion CNY | 0.55% |
2011 Q4 | 4.05 Billion CNY | 0.0% |
2011 Q2 | 4.75 Billion CNY | 0.0% |
2010 Q4 | 4.03 Billion CNY | 0.0% |
2010 Q2 | 3.73 Billion CNY | 0.0% |
2010 FY | 4.03 Billion CNY | 10.79% |
2009 FY | 3.63 Billion CNY | 6.06% |
2009 Q4 | 3.63 Billion CNY | 0.0% |
2009 Q2 | 3.66 Billion CNY | 0.0% |
2008 Q4 | 3.43 Billion CNY | 0.0% |
2008 FY | 3.43 Billion CNY | 30379.52% |
2007 FY | 11.25 Million CNY | -88.57% |
2006 FY | 98.44 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 229.69 Million HKD | -2081.328% |
Lee & Man Chemical Company Limited | 1.22 Billion HKD | -307.606% |